Form4insider filings, from the source

SEC Form 3 · accession 0000892712-16-001609

Cellectar Biosciences, Inc. · CLRB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Apr 14, 2016
Accepted (ET)
Apr 25, 2016 · 3:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001279704

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———469,484D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Common Stock Purchase Warrants$3.04holding———Apr 20, 2016Apr 20, 2021Common Stock469,484—D